Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting

2023-509142-35-00 Atrial fibrillation after stress (e.g., noncardiac surg 6 2024-01-29
COLchicine in BElgium in patients with coronary artery disease after Percutaneous Coronary Intervention Recruiting

2023-505028-74-00 Coronary artery disease 5 2024-01-29
A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emis… Recruiting

2023-506971-89-00 Coronary Artery Disease 5 2024-01-25
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 4-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1… Recruiting

2023-508543-42-00 Chronic heart failure 1 2024-01-22
Clinical Trial with Adipose Tissue Stem Cells on Biological Matrix for the Treatment of Venous Ulcer of the Lower Limbs. Recruiting

2024-513151-33-00 Venous ulcer of the lower limbs 9 2024-01-19
The Colchicine heart failure preserved trial Recruiting

2023-506207-26-00 Heart failure with preserved ejection fraction (HFpEF) 5 2024-01-18
Pharmacokinetics of inhaled levosimendan: a pilot study Recruiting

2024-514318-11-00 heart failure 2 2024-01-17
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE) Recruiting

2023-504340-34-01 Coronary artery disease 6 2024-01-11
Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, o… Recruiting

2022-500717-64-00 cardiac arrest 4 2023-12-27
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 aortic valve stenosis 6 2023-12-21
Early Initiated Vasopressor Therapy in the Emergency Department - A Multi-center Randomized Controlled Trial (VASOSHOCK) Recruiting

2023-504584-16-00 Hypotension 5 2023-12-08
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in… Recruiting

2023-504351-26-01 Pulmonary arterial hypertension (group I) 11 2023-12-06
Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, ph… Recruiting

2023-504041-31-00 ATTR Cardiac Amyloidosis 4 2023-11-17
Intravenous Fish Oil based Lipid Emulsion to enhance recovery in High-Risk Cardiac Surgery Patients: a phase II multicenter trial Recruiting

2023-503490-38-00 critical illness, intensive care unit (ICU), surgery 4 2023-11-15
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
Expression-linked and R-ISS-adapted stratification for first line therapy in multiple myeloma patients (ELIAS) Recruiting

2022-500453-16-00 Multiple Myeloma 4 2023-10-30
Optimal medical treatment of difficult-to-treat hypertension. Recruiting

2024-517628-20-00 hypertension 11 2023-10-24
Effects of combined diuretic therapy on exercise capacity, alveolar-capillary diffusion and maintenance of euvolemia in chronic congestive h… Recruiting

2024-519565-21-01 congestive heart failure 5 2023-09-21
VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED … Recruiting

2022-500035-36-01 Acute heart failure with pulmonary congestion 6 2023-09-14
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 acute venous thromboembolism event 5 2023-08-12
Sacubitril/valsartan in the prevention of disease progression in patients with an ancient arrhythmogenic service - ARNI-ARVC multicentre ran… Recruiting

2024-517412-29-00 arrhythmogenic in the old space of cardiomyopathy 5 2023-07-10
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to evaluate Efficacy and Safety of Empagliflozin in the prevention of Cardioto… Recruiting

2024-515495-13-00 Cardiotoxicity. The study population will consist of p 5 2023-07-06
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting

2022-500587-35-01 Stroke 5 2023-07-06
Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpo… Recruiting

2024-513811-29-00 Cardiogenic Shock 5 2023-07-03